The Ras/Raf/MEK/ERK pathway is essential for regulating cell growth, blood vessel formation, and changes in liver cells caused by growth factors, making it a possible treatment target for HCC. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.